NCT00216788View on ClinicalTrials.gov

The Effect of Nexium on Transmucosal Esophageal Leak

PHASE1UnknownINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
RefluxEsophagitisBarrett's Esophagus
Interventions
DRUG

Esomeprazole (Nexium) 40 mg/day

Trial Locations (1)

19096

Lankenau Hospital, Wynnewood

Sponsors

Lead Sponsor

Main Line Health
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Sharpe-Strumia Research Foundation

OTHER

collaborator

Cancer Research Foundation of America

OTHER

lead

Main Line Health

OTHER